This is a routine plan amendment with no immediate share issuance. Monitor future 6-K filings for actual grant activity, especially given the company's $10M market cap and history of equity raises.
Price Chart
Executive Summary
IceCure Medical's Board increased the shares reserved under its 2024 Employee Equity Incentive Plan by 2.5M (from ~112,667 to ~2.6M), enabling future equity grants. This administrative move has no immediate financial impact but incrementally raises potential dilution, particularly for a $10M market-cap company with a history of share issuances.
Key Facts
- Board approved increase in ordinary shares reserved under 2024 Employee Equity Incentive Plan by 2,500,000 shares.
- Reserved shares expanded from 112,667 to 2,612,667.
- The plan is for employee equity incentives; no immediate issuance or pricing was disclosed.
- Filing incorporated by reference into several prior F-3 and S-8 registration statements.
Financial Impact
2.5M additional shares authorized for incentive grants; maximum potential dilution of approximately 3.4% based on 73.1M shares outstanding as of year-end 2025.
Risk Factors
- Increased share reserve may lead to future equity grants that dilute existing holders.
- No material operational catalyst — stock may drift on lack of news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-090065 |
| Document: 0001213900-26-090065-index-headers.html | 0001213900-26-090065 |
| Document: 0001213900-26-090065-index.html | 0001213900-26-090065 |
| Document: 0001213900-26-090065.txt | 0001213900-26-090065 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.10 | awaiting T+60 | — | $1.00 (−9.09%) |
Oct 5, 2026 20d ago | 6-K | $1.27 | awaiting T+60 | — | $1.00 (−21.26%) |
Oct 5, 2026 21d ago | 6-K | $1.54 | awaiting T+60 | — | $1.00 (+35.06%) |
Sep 10, 2026 6w ago | 6-K | $2.14 | awaiting T+60 | — | $1.00 (−53.27%) |
Aug 24, 2026 9w ago | 6-K | $2.27 | awaiting T+60 | — | $1.00 (−55.95%) |
Aug 19, 2026 9w ago | EFFECT | $2.52 | awaiting T+60 | — | $1.00 (+60.32%) |
Aug 14, 2026 10w ago | 6-K | $2.82 | awaiting T+60 | — | $1.00 (−64.54%) |
Aug 12, 2026 10w ago | 6-K | $3.11 | awaiting T+60 | — | $1.00 (−67.79%) |
Jul 6, 2026 16w ago | EFFECT | $4.61 $1.59 | ▲ +65.51% | ▲ +67.23% | $1.00 (+78.31%) |
Jun 26, 2026 17w ago | 6-K | $5.26 $1.95 | ▲ +62.93% | ▲ +67.31% | $1.00 (+80.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers